Home > Boards > US Listed > Cannabis > Global Consortium Inc. (GCGX)

Re: Mickey4 Post# 19980 Here it is in its

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
abazaba375 Member Profile
Member Level 
Followed By 590
Posts 51,432
Boards Moderated 4
Alias Born 12/08/10
160x600 placeholder
abazaba375 Member Level  Friday, 10/18/19 01:04:54 PM
Re: Cappello post# 19985
Post # of 26874 
Re: Mickey4 Post# 19980
Here it is in its entirety:

GCGX is about to revolutionize the pot industry and you have a front row seat to the action.
Global Consortium, Inc.

Last Price: $0.0197 | Website | SEC Filings | Latest News

While the recent attack on Saudi oil and the upcoming fed announcement steal the headlines.

Investors are asking, “Where can we hide?”

The market is nearing all-time high levels, but we still don’t have a trade deal.

With so much uncertainty, and catalysts around the corner, certain stocks and sectors are off limits.

But you know what?

Others, like the THC and CBD industry, are set to thrive… regardless if there is:

Trade War
An Oil Crisis
Or a Global Currency Debasement
You see, the growth numbers in the THC and CBD sector are just staggering.

In fact, CBD products alone, are expected to be worth $3B to $6B next year, and balloon upwards to $8B-$15B within the next five years, according to Wall Street analysts like Michael Lavery.

And despite all the massive growth potential… there is one company that stands head and shoulders above the rest…

It will blow your mind when you hear about what they’re attempting to pull off…

Global Consortium Inc.


Global Consortium Inc. (OTC: GCGX): While the legal cannabis market is a new thing. Many of the top companies in the space are just copying each other, fearful of taking chances, with the desire to play it safe.

However, that is what makes GCGX so special. The firm isn’t trying to just be another cannabis company.

Not at all.

In fact, the company has put together a plan to build the first cannabis mall in the United States.

According to early estimates, it’s expected to be the largest manufacturing facility of THC and CBD distillates and edibles in the U.S.

The firm is eyeing a 64,000 square foot facility that will allow it to manufacture, distribute, cultivate, and deliver THC and CBD products.

Some of you may already be familiar with GCGX’s brands…

Indulge Oils develops high-quality THC and CBD products, the California-based company prides itself on its ability to extract and produce premium THC and CBD products for patients suffering and are in need of medical attention.

And of course, Infused Edibles, which has served its community for over a decade, garnering awards along the way.

This triple-threat of potential revenue streams… makes GCGX a serious candidate for breakout stock of 2019-20.

Now, let’s take a closer look at the technicals and the stock chart.

GCGX Stock Chart

On September 17, 2019, GCGX closed at $0.0197 per share. The firm’s stock price has traded in a range between $0.0085 and $0.052 over the last 52 weeks.

However, you don’t have to be a master at reading stock charts to know that GCGX has been trending one direction recently…


In fact, since it hit its lows last month, GCGX has seen its stock price rise a whopping 97%.

Now, you might be thinking, “How can I chase a stock that has gone on such a run already?”

The answer is upside potential.

You see, a lot of times, after stocks make parabolic moves, they need time to digest and get comfortable at its new stock price before the buyers step in again and press the stock even higher.

How much higher can GCGX go?

Now, my crystal ball is broken, so I can’t give you an answer with certainty.

However, GCGX currently offers the opportunity to profit by up to 163% from current levels, making the stock a cheap buy at current levels and a low risk/high reward trade setup.

Latest Headlines in GCGX

Global Consortium, Inc., Negotiates 5-Year Lease in Sacramento
COCONUT CREEK, Fla., Sept. 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Global Consortium, Inc., (GCGX) has negotiated a revised lease with an option to purchase 25,000 square feet of the building the company currently leases in Sacramento. Global is currently trying to secure a First Right of Refusal on the remaining 39,000 sq ft of the building.
The new lease and purchase option will be between the building owner and Global Consortium, Inc.
Leasing a larger portion of the building gives the Company time to get multiple parts of the business operational prior to purchasing the building.
Global will use 5,000 sq feet for Indulge Oils and Infused Edibles manufacturing operations, as well as manufacturing for White Label deals. Another 5,000 sq feet will be used for Delivery and Distribution, which is expected to be operational before the end of 2019.
The remaining 15,000 sq ft will be used to house cultivation and additional manufacturing opportunities.
Following the issuance of the Certificate of Occupancy, Indulge Oils will begin manufacturing its THC products for sale.
Bottom Line: Big Company Moves At Little Guy Prices.

The THC and CBD industry is exploding. Everyone knows it, but as an investor and trader, you always have a decision.

Do you go for the play-it safe companies… or do you invest in stocks that have the potential to transform the way the world views an industry?

GCGX has that game-changing potential and has a date with destiny as it embarks on developing the first cannabis mall in the United States.

Will you be picking up shares at these levels providing you with an opportunity to profit by up to 163% starting Wednesday? Or is this just another opportunity you’ll let slip by?

For your due diligence, visit here:


Warm Regards,

Alexander Reeves
Thanks Cap.
Mickey4 on 10/6/2019 11:40:49 PM
Great post Cappello; keep up the good job
Jp_SHMP on 10/7/2019 7:50:15 AM

Report TOS

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist